Impact

FDA regulation

The Need

21 CFR Part 212 (cGMP) regulations call for strict control over production of radio-pharmaceuticals for PET (Positron Emission Tomography).  Quality Control (QC) is the only part of production process that is not automated and consists of 12 tests relying on a complex set of poorly traceable manual procedures and subjective assessments.  This results in high cost of GMP compliance, high risk of non-compliance and throughput challenges.   

The Solution

Trace-Ability has enabled complete automation of radio-pharmaceutical QC testing on a very simple platform based on proven hardware and software.  Tracer-QC consumables eliminate any need for cleaning and all cross-contamination risks.  The user adds sample, starts the process and walks away with a complete QC report generated automatically. Of all automated solutions that have been contemplated to date Tracer-QC is the simplest, easiest to use and most compact.

The Result

Complete traceability and objectivity that are achieved with Tracer-QC™ maximize cGMP compliance, increase throughput and reduce operating costs.

Learn More about Tracer-QC

Contact Trace-Ability for customer or investor inquiries.

Contact Us